XML 33 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
STOCK OPTIONS
12 Months Ended
Dec. 31, 2015
Notes to Financial Statements  
NOTE 16. STOCK OPTIONS

On October 30, 2007, our stockholders approved and the Board of Directors adopted an amendment to the 2003 Executive and Employee Stock Option Plan (the "Plan") to increase the maximum aggregate number of shares of common stock reserved for issuance under the Plan from 1.2 million shares (already reserved against outstanding options) to 1.7 million shares. Except for the increase in the number of shares covered by the Plan, the Plan remained otherwise unchanged. In 2001, the Board of Directors adopted the 2001 Executive and Employee Stock Option Plan which reserved for issuance 1,200,000 stock options. Stock options typically have a ten-year life and currently vest over a seven year period.

 

In July of 2012, the stockholders approved the 2012 Share Incentive Plan covering a total of 750,000 shares of common stock issuable upon exercise of options to be granted under the plan. At December 31, 2015 approximately 40,333 remain to be issued in this plan.

 

In July of 2015, the stockholders approved the 2015 Executive and Employee Stock Option Plan covering a total of 2,000,000 shares of common stock issuable upon exercise of options to be granted under the plan. At December 31, 2015 approximately 1,479,078 remain to be issued in this plan.

 

The status of our stock options and stock awards are summarized as follows:

 

    Number of
Options
    Weighted Average
Exercise
Price
 
Outstanding at December 31, 2013     2,467,046     $ 3.55  
                 
Granted     592,000     $ 3.88  
Exercised     (107,000 )   $ 2.17  
Cancelled and Forfeited     (87,857 )   $ 2.80  
Outstanding at December 31, 2014     2,864,189     $ 3.69  
                 
Granted     830,922     $ 2.21  
Exercised     (97,500 )   $ 2.25  
Cancelled and Forfeited     (466,164 )   $ 3.57  
Outstanding at December 31, 2015     3,131,447     $ 3.38  
                 
Exercisable at December 31, 2015     1,424,036     $ 4.28  

 

The number and weighted average grant-date fair values of options non-vested at the beginning and end of 2015, as well as options granted, vested and forfeited during the year was as follows:

 

Exercise Prices     2014 Number Outstanding     2014 Options Exercisable     Granted     Exercised     Vested     Cancelled     Forfeited     2015 Number Outstanding     2015 Options Exercisable     Weighted Average Remaining Contractual Life  
$ 2.25       309,500       309,500       -       97,500       -       212,000       -       -       -       -  
$ 2.93       35,000       35,000       -       -       -       35,000       -       -       -       -  
$ 6.93       20,000       20,000       -        -       -       -       -       20,000       20,000       1  
$ 8.66       97,857       97,857       -        -       -       7,858       -       89,999       89,999       2  
$ 7.10       12,125       12,125       -        -       -        -       -       12,125       12,125       2  
$ 7.68       7,500       7,500       -        -       -        -       -       7,500       7,500       2  
$ 7.18       50,000       50,000       -        -       -        -       -       50,000       50,000       3  
$ 7.33       131,190       114,346       -        -       16,844       27,135       -       104,055       104,055       3  
$ 6.60       500       500       -        -       -        -       -       500       500       4  
$ 8.32       61,428       48,060       -        -       357       24,286       -       37,142       24,131       4  
$ 7.85       7,500       5,357       -        -       1,071        -       -       7,500       6,428       4  
$ 7.45       100,000       100,000       -        -        -        -       -       100,000       100,000       5  
$ 6.00       30,000       24,000       -        -       6,000        -       -       30,000       30,000       5  
$ 2.46       68,446       58,704       -        -       1,428       27,731       -       40,715       32,401       5  
$ 1.89       50,000       28,572       -        -       7,143        -       -       50,000       35,715       5  
$ 3.08       10,000       5,716       -        -       1,429        -       -       10,000       7,145       5  
$ 2.81       15,000       6,429       -        -       2,143        -       -       15,000       8,572       6  
$ 2.80       7,143       3,877       -        -       714        -       -       7,143       4,591       6  
$ 2.79       46,000       33,334       -        -       10,667        -       -       46,000       44,001       7  
$ 2.54       216,000       92,933       -        -       34,400       16,404       -       199,596       110,929       7  
$ 3.79       100,000       40,000       -        -       20,000        -       -       100,000       60,000       7  
$ 2.50       10,000       2,000       -        -       2,000        -       -       10,000       4,000       8  
$ 6.00       50,000       37,778       -        -       6,000        -       -       50,000       43,778       8  
$ 2.97       42,000       27,333       -        -       7,333        -       -       42,000       34,666       8  
$ 2.20       45,000       28,333       -        -       8,333        -       -       45,000       36,666       8  
$ 2.09       750,000       187,500       -        -       187,500        -       -       750,000       375,000       8  
$ 3.90       213,000       -       -        -       53,250        -       -       213,000       53,250       9  
$ 3.81       169,000       -       -        -       45,250        -       105,750       63,250       45,250       9  
$ 3.63       35,000       -       -        -       8,750        -        -       35,000       8,750       9  
$ 4.30       50,000       -       -        -       12,500        -        -       50,000       12,500       9  
$ 4.05       30,000       -       -        -       7,500        -        -       30,000       7,500       9  
$ 4.07       45,000       -       -        -       8,750        -       10,000       35,000       8,750       9  
$ 3.50       50,000       -       -        -       12,500        -       -       50,000       12,500       9  
$ 2.25       -       -       100,000        -       33,333        -        -       100,000       33,333       10  
$ 1.95       -       -       75,000        -       -        -        -       75,000       -       10  
$ 2.13       -       -       65,000        -        -        -        -       65,000       -       10  
$ 2.00       -       -       225,922        -        -        -        -       225,922       -       10  
$ 1.77       -       -       155,000        -        -        -        -       155,000       -       10  
$ 2.87       -       -       100,000        -        -        -        -       100,000       -       10  
$ 2.48       -       -       10,000        -        -        -        -       10,000       -       10  
$ 2.78       -       -       10,000        -        -        -        -       10,000       -       10  
$ 2.30       -       -       50,000        -        -        -        -       50,000       -       10  
$ 3.78       -       -       20,000        -        -        -        -       20,000       -       10  
$ 3.38       -       -       20,000        -        -        -        -       20,000       -       10  
                                                                                     
          2,864,189       1,376,754       830,922       97,500       495,196       350,414       115,750       3,131,447       1,424,036          

 

 

    Number of
Options
    Weighted Average
Grant Date
Fair
Value
 
Non-vested at January 1, 2015     1,487,435     $ 3.11  
                 
Granted in 2015     830,922     $ 2.21  
Vested in 2015     (495,196 )   $ 3.06  
Forfeited in 2015     (115,750 )   $ 3.83  
Non-vested at December 31, 2015     1,707,411          

 

Common shares required to be issued upon the exercise of stock options and warrants would be issued from our authorized and unissued shares. We calculated the fair value of issued options utilizing a trinomial lattice with an expected life calculated via the simplified method as we do not have sufficient history to determine actual expected life.

 

The grant date fair value of options granted in 2015 was estimated on the grant date using a trinomial lattice option-pricing model and the following assumptions: expected volatility of 53% - 54%, expected term of 4-10 years, risk-free interest rates of 0.2% - 1.58%, and expected dividend yield of 0%.

 

The grant date fair value of options granted in 2014 was estimated on the grant date using a trinomial lattice option-pricing model and the following assumptions: expected volatility of 53% - 54%, expected term of 4-10 years, risk-free interest rates of 0.6%, and expected dividend yield of 0%.

 

The grant date fair value of options granted in 2013 was estimated on the grant date using both binomial and trinomial lattice option-pricing model and the following assumptions: expected volatility of 43% - 47%, expected term of 3-5 years, risk-free interest rates of 0.4% - 0.6%, and expected dividend yield of 0%.

 

As of December 31, 2015, the aggregate intrinsic value of all stock options outstanding and expected to vest was approximately $102,992 and the aggregate intrinsic value of currently exercisable stock options was approximately $11,250. The intrinsic value of each option share is the difference between the fair market value of our common stock and the exercise price of such option share to the extent it is "in-the-money". Aggregate intrinsic value represents the value that would have been received by the holders of in-the-money options had they exercised their options on the last trading day of the year and sold the underlying shares at the closing stock price on such day. The intrinsic value calculation is based on the $2.10 closing stock price of our common stock on December 31, 2015, the last trading day of 2015. The total number of in-the-money options outstanding and exercisable as of December 31, 2015 was approximately 410,715.

 

As of December 31, 2014, the aggregate intrinsic value of all stock options outstanding and expected to vest was approximately $2,265,825 and the aggregate intrinsic value of currently exercisable stock options was approximately $1,101,468. The intrinsic value of each option share is the difference between the fair market value of our common stock and the exercise price of such option share to the extent it is "in-the-money". Aggregate intrinsic value represents the value that would have been received by the holders of in-the-money options had they exercised their options on the last trading day of the year and sold the underlying shares at the closing stock price on such day. The intrinsic value calculation is based on the $3.68 closing stock price of our common stock on December 31, 2014, the last trading day of 2014. The total number of in-the-money options outstanding and exercisable as of December 31, 2014 was approximately 819,231.

 

The total intrinsic value of options exercised during the years ended December 31, 2015, 2014, and 2013 was approximately $51,575, $229,135, and $76,000, respectively. Intrinsic value of exercised shares is the total value of such shares on the date of exercise less the cash received from the option holder to exercise the options. The total cash proceeds received from the exercise of stock options was approximately $209,250 and $87,475, and $48,000 for the years ended December 31, 2015, 2014 and 2013, respectively.

 

The total fair value of options granted during the years ended December 31, 2015, 2014, and 2013 was approximately $932,771, $1,107,280, and $672,000, respectively. The total fair value of option shares vested during the years ended December 31, 2015, 2014, and 2013, was approximately $612,464, $412,638, and $637,000, respectively.

 

During the year ended December 31, 2015, we issued 33,520 common shares in exchange for 114,500 non-employee stock options and 80,980 common shares (via stock swaps).

 

During the year ended December 31, 2014, we issued 73,699 common shares in exchange for 107,000 employee and non-employee stock options and 33,301 common shares (via stock swaps). Net proceeds from the issuance of common shares along with the shares received in the stock swap exercises were approximately $80,475 for the year ended December 31, 2014.

 

Stock compensation cost recognized for the years ended December 31, 2015, 2014, and 2013 was approximately $575,000, $388,000, and $506,000, respectively. As of December 31, 2015, there was approximately $1,570,000 of total unrecognized stock-based compensation cost, related to unvested stock options granted under the Amended Plan. This cost is expected to be recognized over a weighted-average period of approximately 4 years.

 

Allocation of stock based compensation expense for the fiscal years ended December 31, 2015, 2014, and 2013 was as follows (in thousands):

 

    2015     2014     2013  
Cost of Sales   $ 3     $ 8     $ 12  
Research and development     39       51       34  
Salaries and related costs     526       329       460  
Total   $ 568     $ 388     $ 506